Search

everythinglearnresearchcommunity

for

Search:↓

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Tofacitinib temporarily regrew hair in a man with alopecia, but its effects didn't last.

Using a special laser can improve how well hair loss treatments get into the skin and hair follicles.

Researchers developed a mouse model that successfully mimics the bladder damage seen in humans after radiation therapy.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

Mice without the IL-6 gene had more hair growth after injury due to higher activity of a related protein, Stat3.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

The document suggests a bacteria plays a significant role in acne rosacea and that white hair can regain color after transplant, meriting more research on reversing grey hair.

A boy with alopecia regrew hair using a vitamin D cream after other treatments failed.

A special hydrogel helps heal skin without scars and regrows hair.

A severe medication reaction required long treatment and led to hair loss and thyroid issues.

Using cidofovir cream for a rare skin disease can cause skin darkening.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

A protein called EGFR protects hair follicle stem cells, and when it's disrupted, hair follicles can be damaged, but blocking certain pathways can restore hair growth.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

The study found new details about human hair growth and suggests that preventing a specific biological pathway could potentially treat hair graying.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

β-Catenin signaling is involved in brain cell growth after injury and could be a therapy target.

Stress stops hair growth in mice by causing early hair growth phase end and harmful inflammation through a specific nerve-related pathway.

Pioglitazone usually doesn't effectively treat or cure lichen planopilaris.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

Epidermolysis bullosa simplex causes easily blistered skin due to faulty skin cell proteins, leading to new treatment ideas.

Low dose oral minoxidil helps regrow hair in permanent chemotherapy-induced alopecia.

A condition with certain scalp changes may come before acne keloidalis nuchae and other similar hair loss disorders.